Positions 126–130 of 130.
66 weeks, 24kg, and triple agonist was the hard part. Full detail below, and I have tried to keep the editorialising out of it. Since the title puts numbers in the shop…
Genuine question, and the title is the question: can we stop arguing about triple agonist until somebody posts a number. Stopped at a low step because there was no…
Something I keep coming back to: reta made me not want food OR water and that is its own problem. The early fullness profile felt different rather than worse. Hard to…
retatrutide — my 21-week log, condensed into one table. I have gone back and forth on this for months. Where the evidence actually stands, since every thread here…
Vendor-level purity averages over time, built from independent results rather than vendor claims. Transparent methodology, open dataset.
Browse resultsunpopular opinion: most of what gets said here about TRIUMPH is guesswork. Change my mind, genuinely — I have no stake in being right about this. The standing caveat,…
Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.
Certified reference materials for peptide identity and purity work.
sigmaaldrich.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference